John Michael Quinn: Insights into Prehospital Whole Blood in Trauma Care
John Michael Quinn, Faculty Lecturer at College of Remote and Offshore Medicine Foundation, Emergency Medicine Physician at Surrey and Sussex Healthcare NHS Trust, shared a post on LinkedIn about a recent article by Jason E. Smith et al. published in NEJM:
“Interesting paper and definitely worth a read.
At face value, it suggests that prehospital whole blood was not superior to component therapy in this trial setting.
But I would be careful not to overinterpret that as meaning whole blood has no value, or that the broader concept should be discarded.
As always, an important study can still leave important questions unanswered.
On scene time and coagulopathy indicators are interesting here.
I would not throw the baby out with the bathwater.”
Title: Prehospital Whole Blood in Traumatic Hemorrhage – a Randomized Controlled Trial
Authors: Jason E. Smith, Rebecca Cardigan, Emily Sanderson, Laura Silsby, Claire Rourke, Ed B. G. Barnard, Peter Basham, Grazia Antonacci, Richard Charlewood, Nikki Dallas, Jane Davies, Elizabeth Goodwin, Annie Hawton, Cara Hudson, Joanne Lucas, Katie Keen, Richard M. Lyon, Brodie Nolan, Gavin D. Perkins, Viona Rundell, Laura Smith, Simon J. Stanworth, Anne Weaver, Tom Woolley, Laura Green
Read the Full Article on NEJM
Stay updated with Hemostasis Today.
-
Sep 3, 2026, 15:42Manuel De Jesus: Innovating Anemia Monitoring Through Biomedical Engineering and Digital Technology
-
Sep 3, 2026, 15:37Hadis Nabipoor: QICL2026 Highlights the Critical Importance of Transfusion Safety
-
Sep 3, 2026, 15:32Gopal Patidar: The ISBT Haemovigilance Working Party Sharing Knowledge and Promoting Best Practices
-
Sep 3, 2026, 15:24Bhalchandra Kawdikar: FDA Approves Rusfertide for Polycythemia Vera
-
Sep 3, 2026, 15:18Massimo Martino: Redefining Allogeneic Transplantation in Myelofibrosis
-
Sep 3, 2026, 15:10Tvisha Subhasish: Extravascular Factor IX Beyond the Circulation
-
Sep 3, 2026, 11:21Thrombotic Microangiopathies: From Clinical Syndrome to Molecularly Targeted Therapy
-
Sep 3, 2026, 10:56Elias Othman: Can an Enzyme Involved in Cell Signaling Become a Target for Antithrombotic Drug Discovery?
-
Sep 3, 2026, 10:42Jared Griffard: Hemorrhagic Shock and Component Blood Transfusion